Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Read more about Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) Read more about Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY)
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery Read more about Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas Read more about Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT Read more about RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer Read more about Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer Read more about Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Ruxolitinib in Combination With Trastuzumab in Metastatic HER2 Positive Breast Cancer Read more about Ruxolitinib in Combination With Trastuzumab in Metastatic HER2 Positive Breast Cancer
Immunotherapy Following Reduced Intensity Conditioning and Allogeneic Stem Cell Transplant for Poor Risk CD30+ Hodgkin Lymphoma Patients Read more about Immunotherapy Following Reduced Intensity Conditioning and Allogeneic Stem Cell Transplant for Poor Risk CD30+ Hodgkin Lymphoma Patients
Entinostat in Patients With Recurrent Advanced Hormone Receptor-Positive Breast Cancer Read more about Entinostat in Patients With Recurrent Advanced Hormone Receptor-Positive Breast Cancer